Quantitative immunoassays for type II collagen and its cyanogen bromide peptides.
This paper describes the development of quantitative immunoassays utilizing mouse monoclonal antibodies which are monospecific to type II collagen. The monoclonal antibodies were characterized and tested extensively for reactivity against a panel of antigens including actin, myoglobin, thyroglobulin, ssDNA, tetanus toxin and different types of collagens including their CnBr-derived peptides. Four monoclonal antibodies having strict monospecificity to type II collagen were selected. Quantitative immunoassays developed with these antibodies can measure either type II collagen in its native conformation or type II collagen-derived cyanogen bromide peptides. The assay conditions such as coating concentration of antigen, monoclonal antibody concentration, second antibody concentration and incubation times were optimized to obtain maximum possible sensitivity. These quantitative immunoassays can be employed to measure type II collagen or type II collagen-derived peptides in low amounts ranging from 20 to 100 ng/ml. The assays can be applied to chondrocyte cultures without interference from serum components or other collagen types.
Srinivas
G R
GR
Department of Pharmacology and Toxicology, University of Rhode Island, Kingston 02881.
Barrach
H J
HJ
Chichester
C O
CO
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D002813:Chondrosarcoma / Q000737:chemistry; D003094:Collagen / Q000032:analysis* / Q000276:immunology; D003488:Cyanogen Bromide; D004797:Enzyme-Linked Immunosorbent Assay; D051379:Mice; D010446:Peptide Fragments / Q000032:analysis*; D051381:Rats; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D010446:Peptide Fragments; D003094:Collagen; D003488:Cyanogen Bromide